4.43 USD
-0.25 (-5.34%)
At close: Jan 30, 2026
4.4011 USD
-0.03 (-0.65%)
After Hours: 1/30/2026, 8:17:22 PM
Overall RPID gets a fundamental rating of 2 out of 10. We evaluated RPID against 58 industry peers in the Life Sciences Tools & Services industry. RPID has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, RPID is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
- In the past year RPID has reported negative net income.
- In the past year RPID has reported a negative cash flow from operations.
- In the past 5 years RPID always reported negative net income.
- RPID had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- RPID has a worse Return On Assets (-52.47%) than 86.21% of its industry peers.
- Looking at the Return On Equity, with a value of -99.91%, RPID is doing worse than 79.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -52.47% | ||
| ROE | -99.91% | ||
| ROIC | N/A |
ROA(3y)-38.74%
ROA(5y)-42.64%
ROE(3y)-47.91%
ROE(5y)-72.28%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- RPID's Gross Margin of 7.72% is on the low side compared to the rest of the industry. RPID is outperformed by 89.66% of its industry peers.
- RPID does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 7.72% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- RPID does not have a ROIC to compare to the WACC, probably because it is not profitable.
- RPID has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for RPID has been increased compared to 5 years ago.
- Compared to 1 year ago, RPID has a worse debt to assets ratio.
2.2 Solvency
- RPID has an Altman-Z score of -6.17. This is a bad value and indicates that RPID is not financially healthy and even has some risk of bankruptcy.
- With a Altman-Z score value of -6.17, RPID is not doing good in the industry: 86.21% of the companies in the same industry are doing better.
- A Debt/Equity ratio of 0.43 indicates that RPID is not too dependend on debt financing.
- RPID has a worse Debt to Equity ratio (0.43) than 62.07% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.43 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -6.17 |
ROIC/WACCN/A
WACC11.08%
2.3 Liquidity
- A Current Ratio of 4.23 indicates that RPID has no problem at all paying its short term obligations.
- Looking at the Current ratio, with a value of 4.23, RPID is in the better half of the industry, outperforming 67.24% of the companies in the same industry.
- A Quick Ratio of 2.95 indicates that RPID has no problem at all paying its short term obligations.
- Looking at the Quick ratio, with a value of 2.95, RPID is in line with its industry, outperforming 58.62% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.23 | ||
| Quick Ratio | 2.95 |
3. Growth
3.1 Past
- RPID shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.82%, which is quite good.
- Looking at the last year, RPID shows a quite strong growth in Revenue. The Revenue has grown by 16.63% in the last year.
- The Revenue has been growing by 11.18% on average over the past years. This is quite good.
EPS 1Y (TTM)9.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)16.63%
Revenue growth 3Y6.49%
Revenue growth 5Y11.18%
Sales Q2Q%3.08%
3.2 Future
- The Earnings Per Share is expected to grow by 9.25% on average over the next years. This is quite good.
- RPID is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.98% yearly.
EPS Next Y6.03%
EPS Next 2Y9.09%
EPS Next 3Y10.48%
EPS Next 5Y9.25%
Revenue Next Year18.65%
Revenue Next 2Y20.05%
Revenue Next 3Y22.69%
Revenue Next 5Y21.98%
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- RPID reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year RPID is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.09%
EPS Next 3Y10.48%
5. Dividend
5.1 Amount
- No dividends for RPID!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
RAPID MICRO BIOSYSTEMS INC-A / RPID FAQ
Can you provide the ChartMill fundamental rating for RAPID MICRO BIOSYSTEMS INC-A?
ChartMill assigns a fundamental rating of 2 / 10 to RPID.
Can you provide the valuation status for RAPID MICRO BIOSYSTEMS INC-A?
ChartMill assigns a valuation rating of 0 / 10 to RAPID MICRO BIOSYSTEMS INC-A (RPID). This can be considered as Overvalued.
Can you provide the profitability details for RAPID MICRO BIOSYSTEMS INC-A?
RAPID MICRO BIOSYSTEMS INC-A (RPID) has a profitability rating of 0 / 10.
What is the expected EPS growth for RAPID MICRO BIOSYSTEMS INC-A (RPID) stock?
The Earnings per Share (EPS) of RAPID MICRO BIOSYSTEMS INC-A (RPID) is expected to grow by 6.03% in the next year.